| Methods |
RCT,
sample size calculation;
time of randomisation not stated;
conversions excluded from analysis. |
| Participants |
n = 15
Inclusion: Carcinoma.
Exclusion: >80 yrs., previous abdominal surgery, rectal tumor < 10cm from anal verge,
advanced local disease, metastatic disease, debilitating concurrent disease, immunomodulatory drugs, blood products within 6 months preoperative.
Approximately 250 pts. excluded because of immunomodulatory drugs. |
| Interventions |
laparoscopic vs. conventional
Conversions: wrong tumor location 1.
Type of resection: left colon 4 vs. 5, rectal 3 vs. 3, segmental 1 vs. 0.
Tumor stage: Dukes A 1 vs. 1
Dukes B 3 vs. 3 Dukes C 4 vs. 4 |
| Outcomes |
Main study criterium: "immunology". Data given for: operative time, analgetics, morbidity, hospital stay |
| Notes |
Operative technique: gas insufflation.
conventional incision: not stated.
Anesthesia/Analgesia: standardized, systemic on demand or pca. drugs: pethidin or morphine.
Evans & Pollock: Design 12, Analysis 13,
Presentation 10, Total 35. |
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Allocation concealment? |
Unclear risk |
B ‐ Unclear |
